Neurogene (NGNE) EPS (Basic) (2013 - 2026)
Neurogene (NGNE) reported EPS (Basic) of -$1.39 for Q1 2026, down 28.7% on a YoY basis from -$1.95 in Q1 2025, and down 23.01% quarter-over-quarter from -$1.13 in Q4 2025.
Neurogene (NGNE) EPS (Basic) (2013 - 2026) Analysis & Trends
Neurogene has reported EPS (Basic) for 14 years, with the latest figure at -$1.39 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 28.7% year-over-year to -$1.39; the trailing twelve-month figure through Mar 2026 stood at -$4.56 (down 4.83% YoY), and the FY2025 full-year result was -$4.24, up 0.93% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.39, down from -$1.13 in the prior quarter.
- The five-year high for EPS (Basic) was $27.76 in Q4 2023, with the low at -$135.89 in Q4 2022.
- Historically, EPS (Basic) has averaged -$12.2 across 5 years, with a median of -$1.09 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 50229.63% — and 2023, when it jumped 120.43%.
- Neurogene's EPS (Basic) stood at -$135.89 in 2022, then jumped by 120.43% to $27.76 in 2023, then plunged by 103.57% to -$0.99 in 2024, then decreased by 14.14% to -$1.13 in 2025, then retreated by 23.01% to -$1.39 in 2026.
- The last three EPS (Basic) figures came in at -$1.39 (Q1 2026), -$1.13 (Q4 2025), and -$0.99 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - | -1.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39 |
| Dec 31, 2025 | -1.13 |
| Sep 30, 2025 | -0.99 |
| Jun 30, 2025 | -1.05 |
| Mar 31, 2025 | -1.08 |
| Dec 31, 2024 | -0.99 |
| Sep 30, 2024 | -1.19 |
| Jun 30, 2024 | -1.09 |
| Mar 31, 2024 | -1.00 |
| Dec 31, 2023 | 27.76 |
| Sep 30, 2023 | -32.67 |
| Jun 30, 2023 | -26.68 |
| Mar 31, 2023 | -28.28 |
| Dec 31, 2022 | -135.89 |
| Sep 30, 2022 | -1.18 |
| Jun 30, 2022 | -0.28 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.27 |
| Sep 30, 2021 | -0.28 |
| Jun 30, 2021 | -0.27 |